Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1084700

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1084700

Biomarker Research Services Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

PUBLISHED:
PAGES: 178 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Biomarkers are widely used in development of drugs. One of the primary processes through which biomarkers are accepted for use in drug development, is the drug approval process. The biomarker is included in the regulatory submission process for drug approval such as Investigational New Drug (IND), Biologics License Disease Indications (BLA), or New Drug Disease Indication (NDA), and are then accepted for use in that specific drug development program. Another process through which biomarkers are accepted for use in drug development is the Biomarker Qualification Program (BQP), which qualifies a biomarker for a particular context of use (COU), independent of a drug approval submission. This pathway is intended for biomarkers that are used in multiple drug development programs. Qualified biomarkers have the potential to offer valuable information that may help during drug development.

Market Dynamics

Factors such as increasing initiatives for development of precision medicine, increasing prevalence of chronic diseases, and increasing demand for development of companion diagnostics, is supporting the growth of global biomarker research services market. For instance, in 2021, National Institutes of Health launched Precision Medicine Initiative (PMI) with an investment of US$ 215 million to accelerate biomedical research and offer clinicians new tools to select therapies that can be used in a more individualized approach with patients. Moreover, potential of biomarkers in disease diagnosis, and in companion diagnostics is expected to boost global biomarker research services market growth. Organizations such as Covance, Inc., Charles River, and others are actively involved in providing biomarker research services.

Key features of the study:

  • This report provides in-depth analysis of global biomarker research services market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global biomarker research services market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Noble Life Sciences, Inc., Reprocell Corporation, Coriell Institute, BioIVT, ICON Plc., SRI International, Inc., Charles River Laboratories, Inc., Nordic Bioscience A/S, Proteome Sciences Plc., and Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global biomarker research services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global biomarker research services market

Detailed Segmentation:

  • Global Biomarker Research Services Market, By Service Type:
    • Biomarker Research Services
    • CDx Research Services
  • Global Biomarker Research Services Market, By Disease Indication:
    • Oncology
    • Cardiovascular Disorder
    • Infectious Disease
    • Neurological Disorder
    • Immunological Disorder
    • Others
  • Global Biomarker Research Services Market, By Region:
    • North America
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • U.S.
      • Canada
    • Europe
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country/Region:
      • Central Africa
      • South Africa
      • North Africa
  • Company Profiles
    • Noble Life Sciences, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • REPROCELL Corporation
    • Coriell Institute
    • BioIVT
    • ICON Plc.
    • SRI International
    • Charles River Laboratories, Inc.
    • Nordic Bioscience A/S
    • Proteome Sciences Plc.
    • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2612

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Service Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Qualified Biomarkers By U.S. FDA
  • Regulatory Scenario
  • U.S. FDA Biomarker Qualification Program
  • Key Highlights
  • Research and Development Collaboration, Mergers, and Acquisitions
  • PEST Analysis
  • Biomarker Development and Testing Technologies
  • Biomarker Development Pipeline
  • Epidemiology

4. Global Biomarker Research Services Market, By Service Type, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Biomarker Research Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Companion Diagnostics (CDx) Research Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Biomarker Research Services Market, By Disease Indication, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Cardiovascular Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Neurological Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Immunological Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Biomarker Research Services Market, By Regions, 2017 - 2028 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Service Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Service Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Service Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Service Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Service Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Service Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Noble Life Sciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • REPROCELL Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Coriell Institute
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • BioIVT
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • ICON Plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • SRI International
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Charles River Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Nordic Bioscience A/S
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Proteome Sciences Plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!